Kimberly-Clark expected to win EU approval for Kenvue in phase 1
Kimberly-Clark NASDAQ:KMB is expected to gain European Union antitrust approval for its planned $40 billion purchase of Kenvue NYSE:KVUE with some remedies.The European Commission is expected to approve the deal with remedies in its phase 1 review, according to traders, who cited a Capitol Forum re…